| ASSET | YEAR | % RETURN |
|---|---|---|
Bitfarms (KEEL) | 2023 | 567.43% |
CleanSpark (CLSK) | 2023 | 425.24% |
Immunome (IMNM) | 2023 | 345.83% |
Opendoor Technologies (OPEN) | 2023 | 279.66% |
Abercrombie & Fitch (ANF) | 2023 | 279.6% |
Oscar Health (OSCR) | 2023 | 266% |
Disc Medicine (IRON) | 2023 | 222.68% |
Duolingo (DUOL) | 2023 | 218.92% |
Camtek (CAMT) | 2023 | 211.96% |
Archer Aviation (ACHR) | 2023 | 211.68% |
SkyWest (SKYW) | 2023 | 210.9% |
Biohaven (BHVN) | 2023 | 204.63% |
Upstart Holdings (UPST) | 2023 | 200.88% |
Amneal Pharmaceuticals, Inc Class A Common Stock (AMRX) | 2023 | 196.1% |
M/I Homes (MHO) | 2023 | 193.06% |
Cimpress (CMPR) | 2023 | 183.76% |
Structure Therapeutics Inc American Depositary Shares (GPCR) | 2023 | 171.73% |
Innodata (INOD) | 2023 | 164.29% |
BW LPG (BWLP) | 2023 | 157.69% |
ELF Beauty (ELF) | 2023 | 156.97% |
Builders FirstSource (BLDR) | 2023 | 153.13% |
Pharvaris (PHVS) | 2023 | 150.67% |
Inter & Co Inc Class A Common Shares (INTR) | 2023 | 150.44% |
Blue Bird (BLBD) | 2023 | 148.71% |
Centessa Pharmaceuticals PLC ADR (CNTA) | 2023 | 147.2% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.